CASE 1-2013: FATAL MANIFESTATION OF MYELOPROLIFERATIVE DISEASE by Hana Ševčíková, Radek Pelouch, Adéla Matějková, Petr Dulíček

Get full text

Is Factor V Leiden a Risk Factor for Fetal Loss? by Petr Dulíček, Ladislav Chrobák, Ivo Kalousek, Lenka Pešavová, Miroslav Pecka, Pravoslav Stránský

Get full text

Antithrombin Deficiency: Frequency in Patients with Thrombosis and Thrombophilic Families by Maria Anna Pejková, Eva Ivanová, Petr Sadílek, Radovan Malý, Zuzana Thibaud, Petr Dulíček

Get full text

P1034: FROM SNAPSHOT TO CONTINUUM: CUMULATIVE TIME IN RESPONSE AS AN EMERGING PROXY FOR THROMBOTIC RISK IN POLYCYTHEMIA VERA by Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian

Get full text

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups by Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian, for the PROUD-PV Study Group

Get full text